Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2458
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda ; volume:12 ; number:1 ; day:4 ; month:9 ; year:2012 ; pages:1-9 ; date:12.2012
BMC public health ; 12, Heft 1 (4.9.2012), 1-9, 12.2012
- Urheber
-
Sempa, Joseph
- Beteiligte Personen und Organisationen
-
Ssennono, Mark
Kuznik, Andreas
Lamorde, Mohammed
Sowinski, Stefanie
Semeere, Aggrey
Hermans, Sabine
Castelnuovo, Barbara
Manabe, Yukari C.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2458-12-736
- URN
-
urn:nbn:de:1111-2016081413461
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sempa, Joseph
- Ssennono, Mark
- Kuznik, Andreas
- Lamorde, Mohammed
- Sowinski, Stefanie
- Semeere, Aggrey
- Hermans, Sabine
- Castelnuovo, Barbara
- Manabe, Yukari C.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cost-effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in HIV patients initiating first-line antiretroviral therapy
Virologic versus immunologic monitoring and the rate of accumulated genotypic resistance to first-line antiretroviral drugs in Uganda
Rapid antiretroviral therapy initiation following rollout of point-of-care early infant diagnosis testing, Uganda, 2018–2021
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Long-term virological outcome in children receiving first-line antiretroviral therapy
Predictors of delayed Anti-Retroviral Therapy initiation among adults referred for HIV treatment in Uganda: a cross-sectional study
Quality of life in patients treated with first-line antiretroviral therapy containing nevirapine or efavirenz in Uganda: a prospective non-randomized study
‘Test and Treat’ Among Women at High Risk for HIV-infection in Kampala, Uganda: Antiretroviral Therapy Initiation and Associated Factors
Antiretroviral treatment failure and associated factors among HIV patients on first-line antiretroviral treatment in Sekota, northeast Ethiopia
Konversionsprozesse in Ankole, Uganda : Initiation, Segregation und Aushandlung
Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy
The Mycobacterium tuberculosisUganda II family and resistance to first-line anti-tuberculosis drugs in Uganda
Cost-effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in HIV patients initiating first-line antiretroviral therapy
Virologic versus immunologic monitoring and the rate of accumulated genotypic resistance to first-line antiretroviral drugs in Uganda
Rapid antiretroviral therapy initiation following rollout of point-of-care early infant diagnosis testing, Uganda, 2018–2021
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Long-term virological outcome in children receiving first-line antiretroviral therapy
Predictors of delayed Anti-Retroviral Therapy initiation among adults referred for HIV treatment in Uganda: a cross-sectional study
Quality of life in patients treated with first-line antiretroviral therapy containing nevirapine or efavirenz in Uganda: a prospective non-randomized study
‘Test and Treat’ Among Women at High Risk for HIV-infection in Kampala, Uganda: Antiretroviral Therapy Initiation and Associated Factors
Antiretroviral treatment failure and associated factors among HIV patients on first-line antiretroviral treatment in Sekota, northeast Ethiopia
Konversionsprozesse in Ankole, Uganda : Initiation, Segregation und Aushandlung
Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy
The Mycobacterium tuberculosisUganda II family and resistance to first-line anti-tuberculosis drugs in Uganda
Cost-effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in HIV patients initiating first-line antiretroviral therapy
Virologic versus immunologic monitoring and the rate of accumulated genotypic resistance to first-line antiretroviral drugs in Uganda
Rapid antiretroviral therapy initiation following rollout of point-of-care early infant diagnosis testing, Uganda, 2018–2021
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Long-term virological outcome in children receiving first-line antiretroviral therapy
Predictors of delayed Anti-Retroviral Therapy initiation among adults referred for HIV treatment in Uganda: a cross-sectional study
Quality of life in patients treated with first-line antiretroviral therapy containing nevirapine or efavirenz in Uganda: a prospective non-randomized study
‘Test and Treat’ Among Women at High Risk for HIV-infection in Kampala, Uganda: Antiretroviral Therapy Initiation and Associated Factors
Antiretroviral treatment failure and associated factors among HIV patients on first-line antiretroviral treatment in Sekota, northeast Ethiopia
Konversionsprozesse in Ankole, Uganda : Initiation, Segregation und Aushandlung
Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy